Phylo
Applied research lab building agentic intelligence to accelerate discovery for every biomedical scientist.
About Phylo
Phylo is an applied research lab building agentic intelligence to accelerate discovery for every biomedical scientist. Founded by Stanford PhD researchers who built the first biology agent (CRISPR-GPT) and the first general-purpose biomedical agent (Biomni), Phylo is pioneering the next generation of AI systems for the life sciences.
The company believes AI agents will fundamentally transform how biomedical research is done, enabling faster and more systematic scientific progress. Phylo's platform is already used by thousands of organizations globally, including ~20 enterprise accounts across top-20 pharma and large biotech companies, with scientists like Feng Zhang actively utilizing the system.
Backed by a $13.5M seed round led by a16z, Menlo Ventures, and Anthropic, and advised by Nobel Prize laureates and pioneering biologists including Feng Zhang, Caroline Bartoszek, and Fabian Theis, Phylo brings together world-class researchers and engineers across AI and biology. Scientific co-founders include Yuri Leskovec and Le Cong, pioneers in AI and CRISPR respectively.
Phylo operates with a culture of excellence and speed — the team moves fast, thinks big, and supports each other. As an early-stage company with a flat organizational structure, every team member has outsized impact on the product and mission to 100X biomedical discoveries through AI.
Benefits
- • Competitive salary ($170K–$275K base for technical roles)
- • Competitive equity at seed stage
- • Full medical, dental, and vision coverage
- • Free therapy sessions
- • Eyewear stipend
- • 401(k) plan
- • Unlimited PTO
- • Lunch and snacks in the office
- • All travel expenses covered for customer-facing roles (flights, meals, accommodations)
- • Regular team offsites and company events
Open positions (1)
Company details
Funding
Total raised
$13.5M
Last stage
Seed
Investors
Founders
Kexin Huang
Co-founder of Phylo, Inc., a Stanford spin-out focused on agentic AI for biomedical research. Leads development of Biomni Lab, an integrated biology environment.
Yuanhao Qu
Co-founder of Phylo, Inc., established in 2025, specializing in AI-driven bioinformatics solutions.
What happens next.
No applications, no recruiter spam. Just the intro.
Confirm the fit
A few questions to make sure this role is the right shape for you. Two minutes.
I pitch you to the company
I write the intro, send it to the founder, and handle the back-and-forth.
A meeting lands on your calendar
If they’re a yes, I book the chat. You show up — that’s the whole job-hunt.